Zevra Therapeutics, Inc.
ZVRA
$11.05
$0.252.32%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 37.89M | 12.17M | -544.00K | 74.71M | -3.10M |
| Total Depreciation and Amortization | 368.00K | 362.00K | 392.00K | 1.65M | 1.65M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -41.70M | 3.04M | 7.19M | -72.67M | 72.00K |
| Change in Net Operating Assets | 9.59M | -10.05M | -2.33M | -7.29M | -6.84M |
| Cash from Operations | 6.14M | 5.52M | 4.71M | -3.60M | -8.22M |
| Capital Expenditure | -35.00K | 31.00K | -554.00K | -213.00K | -99.00K |
| Sale of Property, Plant, and Equipment | 43.98M | -141.00K | 589.00K | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 35.68M | 337.00K | -4.61M | 12.15M | 10.64M |
| Cash from Investing | 79.62M | 227.00K | -4.58M | 11.93M | 10.54M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -60.09M | 0.00 | 0.00 | 0.00 | -372.00K |
| Issuance of Common Stock | 9.92M | 2.55M | 6.53M | 1.38M | 1.98M |
| Repurchase of Common Stock | -2.64M | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -52.80M | 2.55M | 6.53M | 1.38M | 1.61M |
| Foreign Exchange rate Adjustments | 233.00K | -322.00K | 64.00K | 658.00K | -372.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 33.19M | 7.97M | 6.73M | 10.37M | 3.56M |